Calcineurin transgenic mice have mitochondrial dysfunction and elevated superoxide production

Area of Science:

• Cardiovascular Biology
• Mitochondrial Physiology
• Molecular Cardiology

Background:

• Calcineurin is a calcium-dependent phosphatase implicated in cardiac hypertrophy.
• Constitutively active calcineurin signaling can lead to pathological cardiac remodeling and heart failure.

Purpose of the Study:

• To investigate the direct impact of calcineurin signaling on mitochondrial function and energetics in the heart.
• To determine if calcineurin activation affects mitochondrial electron transport chain (ETC) complexes and reactive oxygen species (ROS) production.

Main Methods:

• Adenovirus-mediated gene transfer in cardiomyocytes and H9c2 cells.
• Generation and analysis of cardiac-specific constitutively active calcineurin transgenic mice (CalTG).
• Mitochondrial isolation and functional assessment of oxygen consumption using a Clark-type oxygen electrode.
• Western blot analysis of ETC subunit expression.

Main Results:

• Calcineurin activation decreased mitochondrial membrane potential and increased superoxide production in vitro.
• CalTG mice exhibited cardiac hypertrophy and developed heart failure.
• Heart mitochondria from CalTG mice showed a ~50% reduction in maximal electron transfer rates.
• Reduced expression of ETC subunits (ND3, CO-I, CO-IV) and elevated superoxide levels were observed in CalTG mice.

Conclusions:

• Calcineurin signaling significantly impairs mitochondrial energetics and electron transport in the heart.
• Increased mitochondrial superoxide production is associated with calcineurin-induced cardiac dysfunction.
• These mitochondrial alterations may be a key mechanism driving calcineurin-mediated heart failure.